What's happening
This bill allows pharmacists to substitute prescribed brand name epinephrine auto-injectors with lower-cost alternatives containing the same ingredients, with patient consent.
Why it matters
Could lower out-of-pocket costs for patients. , since pharmacists must only offer alternatives that have a lower unit price, directly addressing the high cost of epinephrine auto-injectors like EpiPens.
Increases patient access to life-saving medication. by allowing more flexibility at the pharmacy counter, potentially reducing delays or barriers when a specific brand is unavailable or unaffordable.
Requires informed patient consent and pharmacist counseling. , ensuring patients know about the substitution and are properly instructed on how to use the alternative device, which is crucial since different auto-injectors may have varying operating procedures.
Overrides existing drug interchangeability lists for this specific case. , letting pharmacists offer alternatives even if they aren’t on the state’s official list of interchangeable products, which could speed up adoption of newer or more affordable devices.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Allow Cheaper EpiPen Substitutes
Plain English, a few words. Used as the page title.
Sponsors
Senator · Senate District 34
2 Co-sponsors
History
- Referred to higher education
- Delivered to assembly
- Passed senateVote 59–0
- Advanced to third reading
- 2nd report cal.
- 1st report cal.981
- Referred to higher education
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Let Pharmacists Switch EpiPens
In Assembly Committee · Higher Education · Sponsor Jonathan Jacobson
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4447
2023-2024 Regular Sessions
IN SENATE
February 8, 2023
Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education
AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine autoinjectors for dispensation by pharmacists
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 6816-a of the education law is amended by adding a new subdivision 6 to read as follows:
6. (a) Notwithstanding subdivision two of this section or any other section of law to the contrary, when a patient is prescribed a brand name epinephrine auto-injector, a pharmacist may substitute an alternate epinephrine auto-injector containing the same active ingredients, dosage form and strength as the brand name product prescribed, ordered or demanded, regardless of whether the alternate epinephrine auto-injector is included in the latest list of interchangeable drug products for the prescribed epinephrine auto-injector device, provided that:
(i) the prescriber does not indicate that the prescription therefor shall be dispensed as written pursuant to paragraph (a) of subdivision six of section sixty-eight hundred ten of this article;
(ii) the alternate epinephrine auto-injector available would reflect a lower unit cost to the purchaser;
(iii) the pharmacist has advised the purchaser of the availability of an alternate epinephrine auto-injector and obtained consent to dispense the alternate epinephrine auto-injector; and
(iv) the pharmacist has counseled the patient or person authorized to act on the patient's behalf on the proper usage and operating features of the alternate epinephrine auto-injector.
(b) For purposes of this subdivision "epinephrine auto-injector" shall have the same meaning as provided in paragraph (b) of subdivision one of section three thousand-c of the public health law.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08848-01-3
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto- injectors for dispensation by pharmacists
Purpose or general idea of bill
This legislation will help ensure affordable access to epinephrine.
SUMMARY OF PROVISIONS:.
Read the full memo (760 words)
Section 1 of the bill adds a new subdivision 6 to education law § 6816-a to authorize a pharmacist to substitute an alternate generic epinephrine auto-injector containing the same active ingredients, dosage, form and strength as the brand name product prescribed, provided: (1) the pres- criber does not indicate that the prescription must be dispensed as written: (2) the alternate epinephrine auto-injector available would cost less: (3) the pharmacist has advised the purchaser of the avail- ability of an alternate epinephrine auto-injector and obtained consent to dispense the alternate; and (4) the pharmacist has counseled the patient or person authorized to act on the patient's behalf on the prop- er usage and operating features of the alternate epinephrine auto-injec- tor.
Section 2 is the effective date.
Justification
While New York generic substitution law permits pharmacists to dispense a lower cost generic drug for a brand name prescription drug unless the prescriber writes "dispense as written". questions have arisen about whether the current law covers epinephrine auto-injectors which are a combination drug and a device for administering the drug or whether an alternate brand name injector may be substituted where the prescribed injector is not available.
This bill would authorize a pharmacist to substitute an alternate epine- phane auto-injector containing the same active ingredients, where: (1) the prescriber does not indicate that the prescription must be dispensed as written. (2) the alternate epinephrine auto-injector available would cost less: and (3) the patient consents.
The extraordinary price increases of EpiPens by Mylan Pharmaceutical, that made national headlines have made access to life saving epinephrine unaffordable for many families. Since acquiring the drug in 2007, Mylan has increased the price of Epipens 600% bringing the cost to over $600 In 2016, Mylan announced they will authorize a generic version of the EpiPen for $300, which is still more than triple the price of EpiPen when they acquired it.
These rate increases hurt all consumers. For those who need this life- saving medication the cost can be prohibitive, even with insurance coverage, depending on the deductible. Some may have to pay the entire cost out-of-pocket while others will have larger co-pays. Families often need multiple epinephrine auto-injectors available at home, school, or daycare. Insurance may not cover multiple packages. More- over, since they expire annually this becomes a yearly expense. Epinephrine auto-injectors are a necessity forcing families to make difficult decisions to cover these costs. Finally, all consumers are impacted by increased insurance premiums and taxpayer dollars spent on epinephrine auto-injectors by EMTs and the State Medicaid program.
Less expensive epinephrine auto-injector alternatives are available, For example, Impax Laboratories makes an alternate epinephrine auto-injector - Adrenaclick - which can be purchased for as little as $140 with a free coupon found on GoodRx. While both products contain epinephrine and are auto-injectors, the injectors differ - Adrenaclick has two caps.while EpiPen has one. Due to this difference in technology, they are consid- ered two different drugs and a pharmacist cannot substitute one for the other. CVS has also recently announced they will offer an alternate epinephrine auto-injector for a fraction of the price of EpiPen.
Since there is technically no generic version of the EpiPen, a pharma- cist cannot substitute Adrenaclick if the prescription specifies EpiPen. A pharmacist may only dispense a less expensive generic version of the Epipen if the prescription is written for an epinephrine auto-injector_
Mylan has spent billions of dollars marketing EpiPen. It has almost become synonymous with epinephrine auto-injector. As a result, most prescribers issue prescriptions specifying EpiPens. Many prescribers are not aware that they should or could write epinephrine auto-injector instead. Many families aren't aware to ask for this either.
This legislation will allow a pharmacist to dispense a less costly alternative epinephrine auto-injector under an EpiPen prescription with the consent of the purchaser. In addition. families can request a phar- macist dispense the less expensive alternative without obtaining a new prescription. New York would be joining more than a dozen states that allow for this substitution. We cannot let a technicality come between New Yorkers and affordable access to this life saving medication.
Prior legislative history
2021-2022 S6393 A3981
2019-2020 S3539
2017-2018 S2489
2015-2016 S8189
Fiscal implications
None
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.